{
    "Clinical Trial ID": "NCT01256008",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Stage 1 Clinical Management",
        "  The group will receive clinical management treatment only each session.",
        "  Clinical Management: Clinical management is a clear contrast method of psychological therapy, which is a half-structured interview and lasting for 20-25 minutes each session. Clinical management will be assigned to both experimental group and controlled group in the first stage of intervention.",
        "  Following are major elements:",
        "  Talk to the subjects to find their main problems; introduce knowledge and medication knowledge about cancer and depression; subjects reporting use of drugs for cancer and depression and a variety of signs and symptoms of the reaction. Encourage patients to adhere to drug treatment and to comply with this research program; The operation of CBT and clinical management should be conducted by the same person as far as possible.",
        "INTERVENTION 2: ",
        "  Stage 1 CBT",
        "  The experimental group will receive CBT each session.",
        "  CBT and clinical management: The subjects will receive standardized CBT treatment regularly for 9 sessions(once per week in the first month and once half a month in the second and third months), and each session will last for about 60 minutes.The treatment includes three steps:Concept stage (the first and second sessions): establishment of therapeutic relationships with the subjects; Skills acquisition and repeat stage (the third session to the 8th session): clarification of sources of stress, patients' cognitive and behavioral response to stress. Application and complete price segment (the 9th session): return visit to test efficacy of psychological intervention."
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Age: 20-65 years;",
        "  Pathologically diagnosed breast cancer patients, with the diagnosis from at least 2 comprehensive clinical attending physicians, in line with clinical diagnosis of breast cancer;",
        "  A week after breast cancer surgery;",
        "  With complaints and symptoms of depression or anxiety",
        "  HAMD-17  8 points or / and HAMA  8 points;",
        "  Have some reading comprehension skills (could complete the self-rating scale independently or with others' help);",
        "  Informed consent",
        "Exclusion Criteria:",
        "  Previous diagnosis of mental disorder or Bipolar Disorder; alcohol and drug abusing history;",
        "  Use antidepressants, antipsychotics or accept any form of psychological treatment, or participation in other clinical trials in the last month",
        "  Patients with cardiovascular disease, liver and kidney dysfunction and other serious diseases;",
        "  Hearing, visual or understanding impairment;",
        "  Severe depression, suicidal tendencies;",
        "  Can not or will not comply with clinical treatment programs based on the physicians' judgment",
        "  Exit criteria:",
        "  Persons with poor compliance during the trial period;",
        "  Persons whose depression increased during the trial period, has serious suicidal tendencies and requires urgent intervention;",
        "  Persons who are believed have other circumstances and should be suspended by Physicians"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Hamilton Depression Rating Scale (HAMD-17)",
        "  The scale(HAMD-17) is used to assessed the depression symptoms of patients.",
        "  The scale range is 0-53.Higher value represents a worse outcome.",
        "  The scale was assessed at baseline,2 week,4 week,8 week,12 week,16 week,24 week",
        "  Time frame: baseline,2 w,4 w,8 w,12 w,16 w,24 w",
        "Results 1: ",
        "  Arm/Group Title: Stage 1 Clinical Management",
        "  Arm/Group Description: The group will receive clinical management treatment only each session.",
        "  Clinical Management: Clinical management is a clear contrast method of psychological therapy, which is a half-structured interview and lasting for 20-25 minutes each session. Clinical management will be assigned to both experimental group and controlled group in the first stage of intervention.",
        "  Following are major elements:",
        "  Talk to the subjects to find their main problems; introduce knowledge and medication knowledge about cancer and depression; subjects reporting use of drugs for cancer and depression and a variety of signs and symptoms of the reaction. Encourage patients to adhere to drug treatment and to comply with this research program; The operation of CBT and clinical management should be conducted by the same person as far as possible.",
        "  Overall Number of Participants Analyzed: 98",
        "  Mean (Standard Deviation)",
        "  Unit of Measure: units on a scale  baseline: 11.52         (3.789)",
        "  2W: 10.23         (3.207)",
        "  4W: 9.80         (3.056)",
        "  8W: 8.71         (3.601)",
        "  12W: 8.01         (3.200)",
        "  16W: 7.42         (3.019)",
        "  24W: 7.01         (3.317)",
        "Results 2: ",
        "  Arm/Group Title: Stage 1 CBT",
        "  Arm/Group Description: The experimental group will receive CBT each session.",
        "  CBT and clinical management: The subjects will receive standardized CBT treatment regularly for 9 sessions(once per week in the first month and once half a month in the second and third months), and each session will last for about 60 minutes.The treatment includes three steps:Concept stage (the first and second sessions): establishment of therapeutic relationships with the subjects; Skills acquisition and repeat stage (the third session to the 8th session): clarification of sources of stress, patients' cognitive and behavioral response to stress. Application and complete price segment (the 9th session): return visit to test efficacy of psychological intervention.",
        "  Overall Number of Participants Analyzed: 98",
        "  Mean (Standard Deviation)",
        "  Unit of Measure: units on a scale  baseline: 13.31         (5.090)",
        "  2W: 11.72         (4.976)",
        "  4W: 9.72         (4.835)",
        "  8W: 7.80         (4.440)",
        "  12W: 5.71         (3.979)",
        "  16W: 5.13         (4.108)",
        "  24W: 4.45         (3.875)"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/98 (0.00%)",
        "Adverse Events 2:",
        "  Total: 0/98 (0.00%)"
    ]
}